Where Tech Meets Bio
Subscribe
Sign in
Home
Podcast
Weekly Highlights
Deep Dives
Sponsored Features
About
Weekly Tech+Bio Highlights #54: Era of Generative Genomics
Era of Generative Genomics, Benchmarking Scientific AI Agents, & Hitting "Undo" on Disease
4 hrs ago
•
BiopharmaTrend
,
Roman Kasianov
, and
Illia Terpylo
2
Biotech in Space: Microgravity, Ventures, and the Path to Production
From public labs to private stations, the near-term outlook for orbital bioprocessing and its first commercial pipelines
Sep 11
•
BiopharmaTrend
and
Illia Terpylo
6
Weekly Tech+Bio Highlights #53: Eli Lilly Opens Access to AI Models Trained on $1 Billion Worth of R&D Data
Is the first anti-aging drug class on the horizon? Also: David Baker’s new venture; grounding AI in chemistry & current state of medchem platforms
Sep 9
•
Roman Kasianov
and
Illia Terpylo
7
Most Popular
View all
The '4th Wave' of AI Drug Discovery is Here, According to This Report
Dec 12, 2024
•
Andrii Buvailo
24
14 Startups in AI Protein Design: Platforms, Specialists, Modular Tools
May 29
•
BiopharmaTrend
and
Illia Terpylo
15
12 Startups in the Digital Twin Healthcare Ecosystem: From Virtual Organs to Optimized Trials
Mar 20
•
BiopharmaTrend
15
The Rise of AI Agents in Biotech, Where Are We Now?
Apr 10
•
Andrii Buvailo
and
BiopharmaTrend
15
13 Foundation Models: Startups, Industry Updates and the Nobel Prize
Mar 28
•
BiopharmaTrend
15
1
11 Biopharma Trends to Watch in 2024
Dec 29, 2023
•
Andrii Buvailo
14
Latest
Top
Discussions
Weekly Tech+Bio Highlights #52: Open AI's Accelerated Cell Reprogramming
Tempus-Paige Digital Pathology Acquisition Deal, Reasoning AIs for Biology & Antibiotics
Aug 26
•
BiopharmaTrend
and
Roman Kasianov
8
Digital Pathology: Slides, AI, & Challenges
Pathology has progressed from glass slides to AI-driven digital diagnostics, promising to transform disease detection, while facing adoption and market…
Aug 14
•
Illia Terpylo
and
BiopharmaTrend
8
Weekly Tech+Bio Highlights #51: Neurosymbolic AI for Biomedical Research
$6B AI Drug Discovery Deal & FDA’s AI Lifecycle Concept for Health Care
Aug 11
•
BiopharmaTrend
and
Roman Kasianov
4
Building the Virtual Cell: AI Foundation Models and Billion-Cell Datasets
From early 2000s and a 2012 milestone to a decade-long quiet—virtual cell modeling is resurging with transformers, perturbation atlases, and…
Aug 7
•
BiopharmaTrend
and
Illia Terpylo
9
Weekly Tech+Bio Highlights #50: How Robust Are Pathology Foundation Models?
CRISPR-GPT, Current Gene Delivery Landscape, & Thought-Controlled iPad
Aug 5
•
BiopharmaTrend
and
Roman Kasianov
8
H1 2025 Recap: Key Signals from the Tech+Bio Frontier
A high-signal summary of some of the most important moves and trends shaping biotech and tech-enabled life sciences in the first half of 2025
Jul 31
•
Andrii Buvailo
12
Weekly Tech+Bio Highlights #49: Radiology AI Grows, Impact Evidence Lags
~$1.8B in new funds and rounds; Can AI Scientists Help Rare Disease Research? & Key Tension in Applying Virtual Cell Models to Drug Development
Jul 28
•
BiopharmaTrend
and
Roman Kasianov
6
Weekly Tech+Bio Highlights #48: Bi-Weekly Overview
AI Protein Design Models, Policy Changes & Industry Funding for Q2
Jul 23
•
BiopharmaTrend
and
Roman Kasianov
6
How Organoids and AI Are Replacing Animal Testing
As FDA & NIH formalize support for non-animal testing, organ-on-a-chip, organoids, and ML-based toxicity models are being integrated into preclinical…
Jul 18
•
BiopharmaTrend
and
Illia Terpylo
14
See all
Where Tech Meets Bio
What does the future hold for us in the "century of biotech"?
Subscribe
Recommendations
View all 6
Noahpinion
Noah Smith
AI Supremacy
Michael Spencer
People vs Algorithms
Troy Young
Special Competitive Studies Project
SCSP
The Connected Ideas Project
Alexander Titus
Where Tech Meets Bio
Subscribe
About
Archive
Recommendations
Sitemap
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
